# FDA Inspection 1172652 - Octapharma Plasma, Inc. - June 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/4c2df356-9641-44b9-8736-69e280c3e5a2
Source feed: FDA_Inspections

> FDA Inspection 1172652 for Octapharma Plasma, Inc. on June 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172652
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1172652 - 2022-06-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/267c3458-7edc-42a1-bb5b-8edb609ef618)
- [FDA Inspection 1036565 - 2017-12-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6b0697a4-0c87-4f89-a0b9-84d51ae64f8c)
- [FDA Inspection 865572 - 2014-02-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/cbcc046c-3de7-4fce-9a6e-21afb13551b7)
- [FDA Inspection 760574 - 2011-12-23](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8db28e52-a2dd-4712-bd57-56bca0de66ef)
- [FDA Inspection 597584 - 2009-07-10](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/702041d2-0f9a-4bb8-afc0-87259a38cb26)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6e8b1ca0-cc63-4e8f-9a4c-a4bb56aedec8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d